Viewing Study NCT03343067


Ignite Creation Date: 2025-12-25 @ 12:45 AM
Ignite Modification Date: 2026-01-05 @ 3:08 PM
Study NCT ID: NCT03343067
Status: TERMINATED
Last Update Posted: 2019-11-27
First Post: 2017-11-13
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate Safety and Efficacy of Elagolix in Participants With Endometriosis With Associated Moderate to Severe Pain
Sponsor: AbbVie
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Endometriosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Endometriosis associated pain View
None Elagolix View
None Non-menstrual pelvic pain (NMPP) View
None Dysmenorrhea (DYS) View